CCDR: Volume 50-6, June 2024: Cancer Vaccines
Download this issue as a PDF (1,326 KB)Published by: The Public Health Agency of Canada
Date published: June 2024
ISSN: 1481-8531
Submit a manuscript
About CCDR
Browse
The PDF for this issue has been updated as of December 2, 2024 with a new catalogue number.
Table of contents
Overview
Efficacy, effectiveness and immunogenicity of reduced HPV vaccination schedules: A review of available evidence
J Montroy, MI Salvadori, N Forbes, V Dubey, S Almasri, A Jirovec, C Yan, K Gusic, A Stevens, K Young, M Tunis
Surveillance
Healthcare-associated infections and antimicrobial resistance in Canadian acute care hospitals, 2018–2022
Canadian Nosocomial Infection Surveillance Program
Device and surgical procedure-related infections in Canadian acute care hospitals, 2018−2022
Canadian Nosocomial Infection Surveillance Program
Scoping Review
Thematic description of factors linked with extended-spectrum beta-lactamase-producing Enterobacteriaceae in humans
J Goltz, C Uhland, S Pearce, C Murphy, C Carson, J Parmley
Epidemiologic Study
Characteristics associated with SARS-CoV-2 testing, infection and vaccine uptake among essential non-healthcare workers in Montréal, 2021
C Caya, D Menzies, J Papenburg, C Yansouni, J Campbell